FDA and EMA on the Same Page for Most Drug Approval Decisions, Analysis Shows

Drug Industry Daily
A study by the FDA and EMA comparing their decisions on drug marketing applications found the two agencies align in most cases — but sometimes reach different conclusions about a drug’s efficacy.

To View This Article:


Subscribe To Drug Industry Daily